Clinical Trial Update: A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study to assess bioequivalence of lisinopril 40 mg tablets under fed conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: Par Pharmaceutical, Inc. | Conditions: To Determine Bioequivalence Under Fed Conditions | Phase 1 | Status: COMPLETED